Karyopharm Announces the Appointment of Brendan Strong as Senior Vice President of Investor Relations and Corporate…
Continue ReadingTag: Karyopharm
Karyopharm Strengthens Leadership Team with Key IR Appointment Ahead of 2025 Pipeline Milestones
NEWTON, Mass., Dec. 9, 2024 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company…
Continue Reading
Karyopharm Announces the Appointment of Brendan Strong as Senior Vice President of Investor Relations and Corporate Communications
NEWTON, Mass., Dec. 9, 2024 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company…
Continue Reading